Answer:
The new drug will not be effective against the treatment of cancer.
Explanation:
The drug will not be effective against the cancer treatment because the drug will inhibit the dimerization of receptor tyrosine kinase (RTK) but as the Ras has undergone mutation due to replacement of one amino acid, it will be constitutively expressed and the drug is not effective in stopping the Ras functioning.
Thus, Gefitinib cannot work against the cancerous cell as it is not potent to stop the functioning of mutant Ras protein.
bc the more the earth tilts the farther away that part of the earth gets from the sun so therefor its not goin to be as hot over there
Chronic lymphocytic leukemia or the CLL is among the most common type of leukemia affecting the adults. The lymphocytic leukemia starts in the lymphocytes. Lymphocytic leukemia is different from the lymphoma (which also occur in the lymphocytes) as it only occurs in the bone marrow and the blood. The person suffering from CLL is susceptible to an array of infections. Among the various infectious agents, the CLL patient is the most susceptible to the Staphylococcus aureus. This agent causes skin infections, pneumonia, toxic shock syndrome and many other life threatening diseases. The person becomes susceptible to its attack as the immunity of his is weakened beacuse of the damage to the lymphoctic cells.
Answer:
the U.S comsumes almost 15% of the worlds energy
Explanation:
yes
